Ten previously undescribed 2,4-diamino-6-(2-naphthylamino )methylpteridines with lipophilic chlorine or long-chain alkyl groups on the naphthyl moiety and either hydrogen or a methyl group on N 10 were synthesized from the appropriate 2-naphthylamine or N-methyl-2-naphthylamine by reaction with 2-amino-5-chloromethylpyrazine-3-carbonitrile and ring closure with guanidine . One analogue with a methyl group at the 7 -position was also prepared . The N 10 -unsubstituted analogues were consistently less active than the N1o-methyl analogues as inhibitors of Pneumocystis carin ii, Toxoplasma gondii, and rat liver dihydrofolate reductase. However the potency of the series as a whole was relatively low against all three enzymes, with the best inhibitors giving IC oo values only in the 0.1-1.0 ~M range and several giving IC 50 values in the 10-100 ~M range. Moreover, while several compounds with IC so values of <10 ~M showed some selectivity for the Pnellmocystis carinii and/or Toxoplasma gondii enzyme relative to the rat liver enzme, the magnitude of this effect was marginal «4-fold). Assays were also performed against purified human dihydrofolate reductase and against wild-type and methotrexateresistant human leukemic lymphoblasts in culture. Activity against the enzyme was very low, the best inhibitors giving only 50-70% inhibition at 10 ~M. Although none of the compounds inhibited the growth of wild-type CEM cells by more than 20% at 1 ~M, several were more active (60-75% inhibition at 1 ~M) against the methotrexate-resistant subline CEM/MTX, which is defective in methotrexate and reduced folate transport, than they were against the methotrexate-sensitive parental CEM cells. Overall the results suggest that 2,4-diamino-6-substituted pteridines with chlorine or long-chain alkyl substituents in the 2-naphthyl moiety and hydrogen or a methyl group on NIO are not likely to be therapeutically useful agents.
Introduction
The use of lipophilic inhibitors of dihydrofolate reductase (DHFR) to block the growth of cells that lack the ability to take up classical folate antagnists like methotrexate (MTX, 1) via carriermediated active transport has been a hallmark of antifolate chemotherapy for more than four decades (1) . Inability to take up reduced folates or classical antifolates with a glutamate side chain is an innate characteristic of many protozoan parasites, including those that cause endemic tropical diseases like malaria, trypanosomiasis, and leishmaniasis. An acquired decrease or loss of the active transport pathway can occur in tumors when they become clinically resistant to MTX, but has the potential to be overcome through the use of lipophilic DHFR inhibitors whose cellular acc:umulation is not dependent on transport.
\ \-ith the "'orldwide spread of AIDS since its in-:ta1 JisC:O\'er; as a clinical entity, the list of mic:roblal spec:ies amenable to chemotherapy with lipophilic antitolates has grown to include a variety of opportunistic organisms that normally pose minimal risk to healthy individuals but can produce life-threatening morbidity when the immune system is impaired. Among these organisms are those responsible for Pneumocystis carinii pneumonia, toxoplasmosis, cryptosporidiosis, and disseminated Mycobacterium avium infection (2) . Well-known lipophilic DHFR inhibitors that have been used clinically as single agents or in combination with other dnlgS to treat one or more of these opportunistic infections are pyrimethamine (2) , trimethoprim (3), trimetrexate (4) , and piritrexim (5) (Chart I). When the more toxic agents to mammalian cells are used, such as 4 and 5, host toxicity can be selectively ablated with leucovorin (5 -formyltetrahydrofolate).
Numerous analogues of 2-5 have been synthesized in the hope of improving potency and species selectivity or achieving more favorable pharmacokinetic properties . With analogues of 4 and 5, these efforts have focused mainly on com- pounds mcdified in the B-ring and compounds in which the aryl-substituted group at the 6-position is altered to increase steric bulk and lipophilicity. Early examples of the latter approach included a number of 2,4-dianlinoquinazolines with a I-naphthyl group liPl<.ed to the 6-position via a NHCH 2 or ° bridge as in structures 6 and 7 (3, 4) or with a 2-naphthyl group and a NHCH z , CH2NH, 0, S, SO, S02, or CONH bridge as in structures 8-12 (3-8) . While these compounds exhibited only modest antibacterial or anticancer activity, several of t..~em produced in vivo results against Plasmodium berghei malaria in mice and Plasmodium Jalciparum malaria in monkeys that were comparable to, or in some cases better than, those of analogues with a substituted phenyl as opposed to a 1-or 2-naphthyl substituent. Subsequently, other 2,4-diaminoquinazolines with either hydrogen or a methyl group at the 5-position, a CH 2 NH or NHCH z bridge at the 6-position, and a larger phenanthrene, anthracene, or pyrene group in the side chain were also described, but were tested only for anticancer activity (9) . In more recent years, 2,4-dianlino-5,6,7,8-tetrahydroquinazolines (13) (10) and 2,4-diaminopyrrolo [2,3- [3] [4] [5] 13) are shown in Chart II. However none of these compounds contained a naphthyl group with long-chain alkyl substitution in either ring, and none of the 2-naphthyl derivatives were halogenated. Because of the availability in our laboratory of 19i, 20i, 23i: R = CH 3 ; R 1= n-C 6 H n ; R2_R4 = H several 2 -naphthylamines substituted at the 3-, 5-, 6-, or 7-position ( 15-17), we decided to take advantage of these rare intermediates to prepare some hitherto undescribed 2,4-diamino-6-l2-(substituted naphthyl )amino ]methylpteridines, and to examine the effect of moving the substituent to different positions of the naphthyl ring on the binding of these compounds to P. carinii and T. gondii DHFR versus mammalian DHFR. The synthesis and in vitro antifolate activity of ten new 2, 4-diamino-6-[2-( substituted naphthyl ) amino ]methylpteridines (19a-j, Schemes 1 and 2) are the subject of this paper.
Chemistry
The synthesis of 19a-i from the 2-naphthyla- ( 18) . The requisite N-methyl-2-naphthylamines 20f-i, precursOi"S of 19f-i, were prepared from the parent amines 20a-d by N-formylation with 97% HC0 2 H followed by reduction of the corresponding N-formyl derivatives 22a-d with LiAlH4 in THF. Neidler the Nformyl nor the N-methyl derivatives have been described previously. Equimolar amounts of the amines were allowed to react with 21 in MeCN solution at room temperature in the presence of K 2 C0 3 until TLC showed disappearance of the starting material, which required several days depending on the amine. The resulting 2-arnino-S- (2-naphthylamino )methylpyrazine-3-carbonitriles 23a-i "vere isolated in yields ranging from 39% to 72% after column chromatography on silica gel and, in some cases, additional recrystallization. Attempts to condense 21 with the Na salts of the previously unknown compounds 2-(N-trifluoroacetyl)amino-5,6-dichloronaphthalene (24) and 2-(tert-butyloxycarbonyl )amino-5 ,6-dichloronaphthalene (25) in DMF led only to dark resinous tars, presumably because of a facile base-catalyzed polymerization similar to that observed with 2-amino-5 -bromometh y lpyrazine -3 -carboni trile in the presence of weak carbon acid salts (19) . IH NMR spectra of the products in d 6 -DMSO (Table  1) showed the pyrazine C 6 proton as a singlet at o 8.3-8 .4 in 23a-e and at 0 8.0-8.1 in 23f-i. Thus N-methylation seemed to have a long-range shielding effect, perhaps reflecting a change in torsional angle of the aryl group relative to the pyrazine. The CH z signal in the 3-n-hexyl analogues 23d showed a slight upfield shift relative to the other non-methylated compounds, presumably reflecting a similar change in torsional angle. The pyrazinyl CH z in aminonitriles 23a-e gave a twoproton doublet at 0 4.3-4.5 (J = 6Hz) resulting from coupling to the NH. Upon addition of a drop of DzO, this doublet collapsed to a singlet. The pyrazinyl CH z in the N-methylated amines 23f-i gave rise to a singlet without addition of D 2 0. Other features of the spectra were consistent with assigned structures. Reaction of aminonitriles 23a-i with one equiva-
lent of guanidine in refluxing EtOH for 8 h afforded pteridines 19a-i in yields ranging from 64% to 87% after recrystallization, generally from DMF. IH NMR spectra of the products (Table 1) Thus, as with the pyrazines, the diamagnetic environment of the CH z protons was affected by the torsional angle between the aryl ring and the heterocycle. Not surprisingly, all the pteridines were practially insoluble in all but the most polar solvents, such as DMF or DMSO. One compound, 19b, was converted to a methanesulfonate salt in the hope that this would improve water solubility, but unfortunately this did not occur. Other attempts were made to solubilize 19b as a glucuronate or isethionate. The isethionate was water soluble but formed a black decomposition product even on gentle warming. Thus it was concluded that stock solutions of these compounds for use in enzyme assays would have to be made up in DMSO as had been done in other recent studies (see for example ref 12). Compound 19j (Scheme 2), with a methyl group at C 7 was made in order to test the possibility that substitution at this position might be more detrimental to mammalian than to P. carinii or T. gondii DHFR binding, and thus might im- Assays were carried out at Indiana University. Numbers in parentheses are the selectivity ratio IC so (rat liver)/IC so (P. carinii) or ICso(rat liver )/ICso( T. gondii). Where the IC so was only determined to be greater than a specified value (e.g., > 1 00 /l-M for 19a against the rat liver enzyme), a selectivity ratio is not listed.
prove selectivity. Because of the possibility that 2-amino-5 -chloromethyl-6-methylpyrazine -3 -carbonitrile would be less reactive than 21 for steric reasons, we chose to use its more reactive N1-oxide (26 ) (20) in the N-alkylation step, and also exten ded the reaction time from 8 h to 22 h . This aflorded NI-oxide 27 in 42% yield. Deoxygenation of 27 with PCl 3 in THF at room temperature then gave 23j (69%), which on ring closure with guanidine yielded 19j (48%) . Interestingly, the bridge CH 2 singlet in the lH NMR spectrum of 19j (0 4.98) occurred at lower field than the corresponding singlet for the 7-unsu sbtituted analogues 19b (0 4.57) and 199 (0 4. 82), suggesting that N 10 methylation and C 7 methylation together have a greater effect on the torsional angle of the bridge than N 10 methylation alone.
Bioassays
A spectrophotometric assay (2 1-23) was used to compare the activity of 19a-j against partially purified DHFR from P . carin ii, T. gondii, and rat liver as was done previously with other series of lipophilic inhibitors from this laboratory (24) (25) (26) (27) (28) . The results, expressed as IC so values under standard assay conditions are presented in Table 2 . The potencies of the different inhibitors varied over a remarkable range against all three enzymes. Against the enzyme from rat liver, the best inhibitors were 19f, 199, and 19i, with IC so values in the 0 .2-0 .5 f.lM range. Compound 19i was comparably active against the P. carinii enzyme, with an I C so of 0.39 f.lM; compounds 19f and 199 were similarly active against the T. gondii enzyme, with IC so values of 0.43 and 0.26 f.lM. All of these compounds were N 10 -methyl derivatives, and almost all were more active than the corresponding N 10 -unsubstituted analogues except 19h, which was slightly more active than 19c against rat liver and T. gondii DHFR but not P. carinii DHFR. Although increased DHFR binding was reported recently for the NlO -methyl derivatives of 2,4-diamino-6-arylaminomethyl-5,6,7,8-tetrahydroquinazolines ( 10), this has not been studied previously with 2,4-diamino-6-arylaminomethylpteridines.
The effect of a chlorine atom on DHFR inhibition appeared to depend on the location of the substituent on the naphthyl ring, and also on w hether the bridge was CH 2 NH or CH 2 NMe. For example, 5,6-dichloro substitution consistently increased activity relative to 6-chloro substitution w hen NIO was unsubstituted (19b versus 19a), but had a negligible effect when N 10 was methylated (19g versus 19f). This contrasted with 5,7-dichloro substitution, which increased activity relative to 6-chloro substitution w hen N 10 was unsubstituted (19c versus 19a) but decreased activity w hen N 10 was methylated (19h versus 19f). The effect of a 3-n-hexyl group on the naphthyl ring also depended on whether or not NlO was methylated, as illustrated by the greater activity of 19i relative to 19d. Interestingly, the effect of NIO methylation seemed to have some species specificity. For example, this effect was smaller for P. carinii than T. gondii or rat liver DHFR in the case of the 5,7-dichloro derivatives 19c and 19h, whereas the opposite was observed in the case of the 3-n-hexyl derivatives 19d and 19i. It should be noted that the standard error of the mean Pteridines/ Vol. 8/No. 3 Table 2 ; most potent and most selective against P. carinii "Asasays were done at Indiana University. Numbers in parentheses are selectivity ratios as defined in Table 1 . Underlined values denote the best potency and/ or best selectivity among the compounds in Table 1 (SEM) in these DHFR assays typically lies within ± 15% of the mean . For purposes of qualitative SAR analysis, shifts in selectivity ratios of at least 3-fold are considered significant.
The effect of 7 -methyl substitution on binding to mammalian DHFR was interesting in that, in the single case where it could be assessed ( 19j versus 19h), there was no difference in activity. This contrasted with the previously observed unfavorable effect of 7 -methyl substitution in classical DHFR inhibitors of both the 2,4-diaminopteridine (20 ) and 2,4-diaminopyrido[ 3,2-d]pyrimidine (29) type. We have previously considered the possibility that bulky 7 -substitution might be therapeutically exploitable if it selectively enhanced binding to P. carinii or T. gondii DHFR ( 30) . However the finding that 7 -methyl substitution had no effect on the mammalian enzyme but pro- Table 4 <20  <20  68  199  52  <20  68  19b  69  20  6 7  19h  23  <20  <20  19c  <20  <20  28  19i  22  <20  <20  19d  <20  <20  <20  19j  25  <20  43  19f  57  <20  74 aDHFR inhibition and cell growth inhibition assays were done at Memorial Sloan-Kettering Cancer Institute as described in refs 9 and 27. The standard assay reaction was performed at 25°C in the presence of 50 J..lM H 2 PteGIu and 100).lM NADPH in 1 mL of MATS buffer [25 mM 2-(N -morpholino)ethanesulfonic acid, 25 mM AcOH, 50 mM Tris, 100 mM NaCl, pH 7.4]. Stock solutions of test compounds were made in DMSO and appropriate dilutions were made so that the final DMSO concentration had no effect on DHFR inhibition or cell growth based on controls without any drug. MTX at a concentration of 10 J..lM gave 100% inhibition of DHFR.. The IC so values of MTX against the wild-type CEM cells and transport-defective CEM/T cells were previously found to be 0 .05 J..lM and 4.0 J..lM (9 ) . duced a 6-fold decrease in binding to the T. gondii enzyme did not support this hypothesis, at least where this small group was concerned. To put these results into perspective, the data for 199-i, the most potent and most selective 2,4-diamino-6-[ (2-substituted naphthyl )amino ] methylpteridines in Table 2 were compared with published IC so and selectivity ratios for eleven other previously described compounds with 1 or 2-naphthyl group and a CH 2 NH or CH 2 NMe bridge, all of which were tested under uniform assay conditions. As shown in Table 3 , four compounds were more active than 199 against P . carinii DFHR, and eight were more active than 19i against T. gondii DHFR. However there was <4-fold selectivity for either the P. carinii or T. gondii enzyme. By comparison, the most selective analogue in this group against P . carinii DHFR, 2,4-diamino-6-( l-naphthylamino )methylpteridine, is lO-fold selective (12) , and the most selective inhibitor of T. gondii DHFR, 2,4-diamino-5-(1-naphthylamino ) methylpyrrolo [ 2,3-d]pyrimidine, is 54-fold selective ( 11) . Although NlO-methyl derivatives of these compounds have not been described, the results in Tables 2 and 3 suggest that they might be more potent but not necessarily more selective .
Compounds 19a-j were also tested as inhibitors of human DHFR and as inhibitors of the growth of MTX-sensitive CEM leukemic lymphoblasts and a subline with defective MTX transport (Table 4) . Three compounds (19b, 19f, and 199) had IC so values of ca. 10 f.lM against human DHFR, whereas the others gave <25% inhibition. When tested against wild-type CEM cells at a concentration of I f.lM (48 h of incubation), none of the compounds gave more than 20% growth inhibition. Four compounds (19b, 199, and 19i) inhibited the growth of the transport-defective cells by 60-75%, suggesting that resistance was partially overcome. Overall, however, these pteridines were much less active than a series of 2,4-diaminoquinazolines with bulky arylamino groups which had been evaluated earlier against wild-type and transport-defective cells (9) . The high cytotoxicity of these lipophilic diaminoquinazoline and the excellent correlation between enzyme inhibition and cell growth inhibition were consistent with efficient passage across the cell membrane . The lower cytotoxicity observed with our pteridines was consistent with their weak DHFR binding.
The results in Table 2 are consistent with the recent work of Piper and coworkers (12) , who found that replacement of CH by N at the 5-poSiDon of a series of 2,4-diamino-6-( arylamino) pyrido[2,3-d]pyrimidines (5-deazapteridines) with diftcrent hydrophobic substituents in the aryl moiety decreased DHFR binding. A possible explanation for this effect is that the lower basicity of the 2,4-diaminopyrimidine moiety is enough to compromise DHFR binding. While we do not have data for the 2,4-diamino compounds, measured pK.,s have been reported for unsubstituted pteridine (pK.,=4.05), 5-deazapteridine (pK.,=3.85), 8-deazapteridine (pK.,=4.11), and 5,8-dideazapteridine (pK.,=3.46) (31) . Thus, all other things being equal, including the microenvironment of the active site, the pKas of 2,4-diarninopteridines and 2,4-diamino-5-deazapteridines would be expected to differ by only 0.1-0.2 unit, which would not be enough, by itself, to explain the observed difference in DHFR binding. The same conclusion has been made about the effect of pK., on the binding of 2,4-diaminoquinazolines with electron-withdrawing groups in the B-ring (32, 33) .
It is of interest that 7 ,8-dialkyl-l ,3-diarninopyrrolo[ 3,2-j]quinazolines, a new class of DHFR inhibitors with small, as opposed to bulky, groups on the heterocyclic moiety, have recently been reported to be potent but non-selective inhibitors of P. carinii DFHR (34) . Thus the role of bulky versus non-bulky substitution as a determinant of selectivity remains uncertain. The 3D sturucture for the ternary complexes of human DHFR with piritrexim (35) has been solved by X-ray crystallography and the structure of the ternary complex of P. carinii DHFR with NADPH and trimethoprim was recently solved (36) . However, structures for the complex of the P. carinii enzyme with either trimetrexate or piritrexim are not yet available and crystallographic studies using ternary complexes of smallmolecule inhibitors with the bifunctional DHFR-TS protein from T. gondii (37) are not yet reported. Information from such studies should prove highly useful in future efforts to design agents that are both potent and selective.
Model 781 double-beam recording spectrophotometer. Shoulders and barely visible peaks are omitted. lH NMR spectra were recorded on a Varian Model EM360L instrument, using Me 4 Si as the reference. TLC analyses were on Whatman MK6F silica gel plates, with spots being visualized under 254-nm illumination. Synthetic procedures are reported for only one or two representative example of each reaction type. Pteridines 19b-j were prepared similarly to 19a, 2-(N -methylamino )naphthalenes 20g and 20h similarly to 20f, and 2-(Nformylamino )naphthalenes 22b-d similarly to 22a. Pyrazines 23c and 23f-i were prepared similarly to 23a except that the reaction time for 23f and 23g was shortened to 20-24 h; 23d was made analogously to 23b. Yields and physical constants are given in Table 1 . Thin-layer chromatographic R,-values and solvent systems for the various groups of compounds were as follows: 2-naphthylamines 20a-i, 0 .5, 3:1 hexane-EtOAc (system 1); 2-(Nformylamino)naphthalenes 22a-d, 0.3, system 1; pyrazines 23a-c, 0 .4, 4 :1 CHCI.l-Me2CO (system 2 ), 0.3-0.5, 20:1 CHCkMeOH; pyrazines 23f-h, 0.5, system 2 or 50:1 CHCkMeOH; pyrazines 23d, 23e, and 23i, 0.5-0.6, system 2; pteridines 19a-e, 0.2, 9:1-CHCI 3 -MeOH (system 3 ); pteridincs 19f-j, 0.4, system 3. Column chromatography was performed on Baker 60-200 mesh silica gel or Baker flash silica gel (40-llm particle size). Unless otherwise specified, final products for elemental analysis were dried in vacuo at 70°C over P 2 0 S • Melting points (not corrected) were determined in Pyrex capillary tubes with the aid of a MelTemp Apparatus (Laboratory Devices, Inc., Cambridge, MA). Microanalyses were done by Quantitative Technologies, Inc., Whitehouse, NT, and were within 0.4% of theoretical values unless otherwise specified.
6-Chloro-2 -(N -formylamino )naphthalene (22a)
6-Chloro-2-naphthylamine (20a) (2 .14 g, 9.53 mmol), prepared from the HCI salt ( 38) by partitioning between EtOAc and 0 .5 N NaOH, was heated in retluxing 97% HC0 2 H (20 ml) for 1 h . The residue after evaporation under reduced pressure was partitioned again between EtOAc and H 2 0, and the organic layer was washed with 5% NaHC0 3 , rinsed with brine, and evaporated. Recrystallization from MeOH gave a light-purple powder melting at 126-127'G EV<qX>ration of the mother liquer gave a second crop; total yield 1.86 g (91%). 
3-n-Hexyl-2-(N-formylamino)naphthalene (22d)
This compound, prepared by the same method as 22a, was isolated in 86% yield and melted at 98-99°C after recrystallization from hexane. 
5,6 -D ichloro-2 -(N -trifluoroacetylamino )naphthalene (22f)
A solution of 20b· HCI (2 .5 g, 0.01 mol) (38) in pyridine (25 ml) was cooled in an ice bath and treated with tritluoroacetic anhydride (2.7 g , 1.9 ml, 13 mmol ) over 5 min. The solution was left to stand at room temperature for 20 h and then partitioned between EtOAc and 2 N HCl. Evaporation of the organic layer, recrystallization from MeOH containing a small amount of H 2 0, and drying on a lyophilizer yielded a beige powder (2.7 g); a second crop yielded an additional 0.2 g (total 2.9 g). The product melted at 161-162°C after recrystallization from MeOH. 
2-(N-tert-Butyloxycarbonylamino)-5,6-dichloronaphthalene (22g)
The free base of ~.6-di..:hl oro-2-naphthylamine (20b), prepared trom lOb He! 2 .~ g , 0 .01 mol) ( 38) as in the S\'n L'C"l5 22a. \ \ ' as dissolved in THF (25 ml ) and treated \\:th di-tert-butyl carbonate (2.2 g, 0 .01 ;"11 0 :
The reaction mixture was stirred at rooCTl :empcratu.re for 5 days, then refluxed tor .30 min and e\'aporated. Recrystallization from hexane , filtered while hot) yielded a tan powder \ 2.6 g . 8:-'\ : m ,p, 137-138°C. under N z at O°C. After being stirred overnight at room temperature, the reaction mixture was returned to the ice bath and quenched by dropwise addition of saturated aqueous Na 2 S0 4 . The solid was filtered and washed with EtOAc. Evaporation o f the combined THF filtrate and EtOAc wash solution left an oil (1.6 g), which on trituration with hot hexane followed by filtration and cooling yielded beige crystals (1.4 g, 71%) ; m.p . 69-70"C after recrystallization from hexane . 
5,6-Dihloro-2-(N-methylamino)naphthalene (20g)
This compound, prepared by the same method as 20r, was isolated in 66% yield and melted at 64-65"C after recrystallization from hexane. 
5,7-Dihloro-2-(N-methylamino)naphthalene (20h)
This compound, prepared by the same method as 20r, was isolated in 77% yield and melted at 87-88 n C after recrystallization from hexane. 
3-n-Hexyl-2-(N-methylamino)naphthalene Hydrochloride (20i · HCI)
The free base 20i, prepared by the same method as 20r, was converted to the HC! salt by passing dry HCI gas through a solution of the crude base in cold MeOH until a precipitate formed (86% yield). After recrystallization from a mixture of EtOAc and hexane the HC! salt melted at 143-144°C. 
2-Amino-5-[N-(6-chloro-2-naphthyl)aminoJmethylpyrazine-3 -carbonitrile (23a)
A suspension of 20a (1.1 g, 5 mmol ) in MeCN (50 ml) was treated with 21 (0.85 g, 5 mmol) and powdered K 2 C0 3 ( 1.4 g, 10 mmo!) and stirred at room temperature for 3 days. The salts were filtered off and the filter cake was extracted with hot EtOAc . The combined MeCN and EtOA:: solutions were evaporated. The product was dissolved in Me 2 CO and evaporated onto silica gel (4 g) . The dried silica gel was placed on top of a column of silica gel ( 50 g, flash grade, 4 x 9 cm), which was eluted with 4 :1 CHCI~-Me2CO . After removal of a fast-moving, brown, non-UV absorbing side product, fractions containing TLChomogeneous product were pooled and evaporated. Recrystallization from MeOH gave a yellow solid (0.6 g) melting at 205-206"C. 
This compound was obtained from 20b · HCl and 21 as descr.ibed in the preceding experiment except that the reaction time was only 20 hand that, instead of being evaporated to dryness, the combined MeCN filtrate and hot EtOAc (2 X 75 mL) washes were concentrated to 50 ml and cooled . The precipitate was filtered, washed with Et 2 0, and dried to a yellow powder; yield 50%. The melting point after colmnn chromatography on silica gel was 224-225°C. (27) A solution of 26 (0.45 g, 2 mmol) in MeCN (20 ml) was treated with 20h (0.37 g, 2 mmol) and powdered K 2 C0 3 (0 .28 g, 2 mmol) and the mixture was stirred at room temperature for 22 h, during which time a yellow precipitated formed. The solid was collected and extracted twice with hot Me2CO (EtOAc was ineffective). The combined Me2CO solutions were evaporated onto silica gel (4 g) and the dried silica gel was placed on top of a silica gel column (40 g, flash grade, 4 x 9 cm). The column was eluted with a large volume of 4:1 CHCI3-Me2CO, but because partial precipitation occurred on top of the column the upper portion of the silica gel had to be extruded from the column and the product extracted from the silica gel with Me 2 C O in a Soxhlet apparatus. The pure fractions from the column and the extract from the Soxhlet apparatus were combined to obtain a yellow powder (0.33 g, 42% yield). After column chromatography on silica gel the product melted above 250°C with decomposition . 
2-Amino-5-[N-(5,7-dichloro-2-naphthyl)-N-methylaminojmethyl-6-methylpyrazine-3-carbonitrile N1-Oxide

2-Amino-5-[N-(5,7-dichloro-2-naphthyl) -N-methylaminojmethyl-6-methylpyrazine-3-carbonitrile (23j)
A suspension of 27 (0.28 g, 0.81 mmol) in THF (10 ml) was stirred in an ice bath and treated with 1.4 g (0 .87 ml, 10 mmol) of PC1 3 . Stirring was continued at room temperature for 1 h, during which time a clear solution formed . The reaction mixture was evaporated under reduced pressure, and the .residue was treated with icecold H 2 0, followed by solid Na 2 C0 3 in small portions (gas evolution) until the pH was neutral. The solid was filtered, washed with H 2 0, and dried in a lyophilization apparatus to o btain a crude product which was purified on a silica gel column in the usual manner. A large yolume of eluent again had to be used to avoid rreciriration on the column. TLC-homogeneous fra..::ti ons \\'ere pooled and evaporated to obtain a \ell o '" rowder (0. 18 g, 69% yield). Recrystallization from Me2CO gave a solid melting above 250"C with decomposition. 
Clean sodium metal (0 .12 g, 5 mmol) was dissolved in absolute EtOH (30 ml), and guanidine hydrochloride (0 .48 g, 5 mmol) was added. After 5 min of stirring at room temperature, amino nitrile 23a (0.57 g, 1.8 mmol) was added and the mixture was refluxed for 8 h . The solvent was evaporated and the residue was triturated with H 2 0 and filtered . Recrystallization from DMF afforded an orange solid (0 .53 g). After recrystallization from DMF the product melted above 250°C with decomposition . 
2,4 -Diamino-6-[N-(6-n-heptyl-2-naphthyl)aminoJ methylpteridine (1ge)
This compound was obtained in 82% yield by the same method as 19a and melted above 250°C with decomposition after being recrystallized from DMF. 
Dihydrofolate reductase assays
Enzyme activity was determined spectrophotometrically at 340 nm with continuous recording as described previously (12, 21, 22, 27) . Concentrated stock solutions of the inhibitors were made up in DMSO and diluted in water. Inhibitor concentrations were designed to produce activities ranging from 10 to 90% of the reaction rate without inhibitor. The standard assay mixture in 1 mL of sodium phosphate buffer (40.7 mM, pH 7.4) contained 92 11M dihydrofolate, 117 11M NADPH, 8 .9 11M 2-mercaptoethanol, and enough of the partially purified enzyme to produce a linear change in absorbance of 0.005 OD units/ min. The final DMSO Preridines/ Vol. 8 / No. 3 concentration \\'as < 1 %. A minimum of four concentrations of inhibitor was required to generate the inhibition curve , and each assay was performed in duplicate. Calculated values of percent inhibition were converted to probits, and regression analysis of the data by the least-squares method was performed using the software program Cricket Graph (Computer Associates, Islandia, NY). The regression coefficient was generally >0.95. In quality control experiments performed routinely with trimethoprim, micromolar IC so values (± SEM) against P. carinii, T. gondii, and rat liver DHFR were 34.7±3.1 (n=31), 2.8±0.4 (n=4), and 133.2±13.9 (n=6), respectively.
